ArticleImmunity, inflammation and disease2026
TRIM28 Promotes Keratinocyte Proliferation and Invasion by Activating NLRP3/SGT1 Axis-Mediated Macrophage Pro-Inflammatory Polarization in an In Vitro Macrophage-Keratinocyte Co-Culture Model.
Article in Immunity, inflammation and disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- TRIM28 Promotes Keratinocyte Proliferation and Invasion by Activating NLRP3/SGT1 Axis-Mediated Macrophage Pro-Inflammatory Polarization in an In Vitro Macrophage-Keratinocyte Co-Culture Model.Immunity, inflammation and disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
backgroundMacrophage-keratinocyte crosstalk is an important component of cutaneous inflammatory responses. Psoriasis is a chronic inflammatory skin disease characterized by dysregulated keratinocyte proliferation and immune dysfunction. While macrophage pro-inflammatory activation is known to exacerbate psoriatic inflammation, the underlying molecular mechanisms remain incompletely understood. TRIM28, a multifunctional regulatory protein, may play a role in this process, but whether TRIM28 regulates macrophage-keratinocyte crosstalk in a psoriasis-relevant inflammatory context remains unclear. The present study was designed as an in vitro mechanistic investigation and does not establish TRIM28 dysregulation in human psoriasis. Therefore, psoriasis is discussed only as a potential disease context, rather than as a conclusion directly supported by the present data.
methodsHuman THP-1 monocytes were differentiated into macrophages and subjected to TRIM28 knockdown or overexpression. Macrophage polarization status was evaluated using a limited panel of conventional M1-like/M2-like-associated markers via flow cytometry (CD68/CD86/CD206), cytokine secretion (ELISA for IL-6, TNF-α, IL-10), and marker expression (iNOS/Arg1 by Western blot). The NLRP3/SGT1 axis and NLRP3 SUMOylation were evaluated using Western blot and co-immunoprecipitation, respectively. Inflammasome-associated activation was further assessed by detecting cleaved caspase-1 and mature IL-1β expression using Western blot and secreted IL-1β using ELISA. The interaction between TRIM28 and NLRP3 was examined by co-immunoprecipitation. Functional impacts on keratinocytes were examined using a Transwell co-culture system with HaCaT cells, measuring proliferation (CCK-8) and invasion (Transwell assays). Rescue experiments involved NLRP3/SGT1 knockdown or SUMOylation inhibition (2-D08).
resultsTRIM28 overexpression promoted macrophage M1-like/pro-inflammatory marker expression, increased pro-inflammatory cytokine secretion, and elevated NLRP3 and SGT1 expression, while enhancing NLRP3 SUMOylation. TRIM28 overexpression also increased cleaved caspase-1, mature IL-1β, and IL-1β secretion, whereas TRIM28 knockdown exerted the opposite effects. Co-immunoprecipitation further showed an interaction between TRIM28 and NLRP3. Conversely, TRIM28 knockdown induced a shift toward an M2-like/anti-inflammatory marker profile and reduced inflammation. In co-culture, TRIM28-overexpressing macrophages significantly enhanced HaCaT cell proliferation and invasion. These effects were reversed by NLRP3/SGT1 silencing or SUMOylation inhibition, supporting the involvement of the NLRP3/SGT1 axis and NLRP3 SUMOylation in TRIM28-mediated actions.
conclusionTRIM28 promotes macrophage pro-inflammatory polarization-like changes by activating the NLRP3/SGT1 axis via NLRP3 SUMOylation, subsequently promoting keratinocyte proliferation and invasion in an in vitro macrophage-keratinocyte co-culture system. These findings suggest a potential mechanism relevant to inflammatory macrophage-keratinocyte interactions, but validation in psoriatic tissues, animal models, and clinical datasets is required before TRIM28 can be implicated in psoriasis pathogenesis. Accordingly, the present study should be interpreted as a basic mechanistic investigation rather than clinical or disease-level evidence linking TRIM28 to psoriasis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.